Everspin Technologies, Inc. (NASDAQ:MRAM – Get Free Report) CEO Sanjeev Aggarwal sold 35,142 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $5.37, for a total value of $188,712.54. Following the transaction, the chief executive officer now directly owns 654,828 shares in the company, valued at approximately $3,516,426.36. This represents a 5.09 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Everspin Technologies Price Performance
NASDAQ MRAM opened at $5.23 on Wednesday. Everspin Technologies, Inc. has a 52-week low of $4.89 and a 52-week high of $8.66. The business’s 50-day moving average price is $5.99 and its 200 day moving average price is $6.01. The firm has a market cap of $115.80 million, a P/E ratio of 87.17 and a beta of 0.79.
Everspin Technologies (NASDAQ:MRAM – Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The business services provider reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.01). Everspin Technologies had a net margin of 2.85% and a return on equity of 2.74%. The business had revenue of $13.20 million during the quarter, compared to analysts’ expectations of $12.50 million.
Institutional Investors Weigh In On Everspin Technologies
Analyst Upgrades and Downgrades
Separately, StockNews.com lowered Everspin Technologies from a “buy” rating to a “hold” rating in a report on Friday, February 28th.
Check Out Our Latest Research Report on MRAM
Everspin Technologies Company Profile
Everspin Technologies, Inc engages in the manufacture and sale of magnetoresistive random access memory (MRAM) products in the United States, Japan, Hong Kong, Germany, Singapore, China, Canada, and internationally. It offers Toggle MRAM, spin-transfer torque MRAM, and tunnel magneto resistance sensor products, as well as foundry services for MRAM products.
See Also
- Five stocks we like better than Everspin Technologies
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- What is a Special Dividend?
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- 3 Healthcare Dividend Stocks to Buy
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Everspin Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everspin Technologies and related companies with MarketBeat.com's FREE daily email newsletter.